The patient has clinical evidence of genital warts (condyloma acuminata), which are caused by low-risk HPV types. Even though she is not currently sexually active and has visible warts, HPV vaccination is still beneficial for protection against other oncogenic strains (especially types 16 and 18). Vaccination is safe and recommended up to age 45.

Toronto Notes 2023 – Gynecology, " STIs and HPV " :

“Vaccination is recommended up to age 45, regardless of prior exposure or visible warts. It may prevent reinfection with or acquisition of high-risk HPV strains.”

MCCQE1 Objectives (Gynecology > 83-3: STIs and HPV):

“Candidates must counsel patients appropriately on prevention, including the role of HPV vaccination, even after exposure or infection.”

Pap testing (B) is routine screening, not management of visible warts. Cryotherapy (D) is optional if the patient desires removal, but she declined treatment. Biopsy (A) is reserved for atypical lesions. Contact tracing (E) is not typically required for HPV warts.

====================================================